Please login to the form below
relugolix
This page shows the latest relugolix news and features for those working in and with pharma, biotech and healthcare.
AbbVie’s blockbuster-in-waiting for endometriosis gets FDA nod
Their relugolix candidate has positive mid-stage results in endometriosis-related pain, uterine fibroids, and prostate cancer, and is currently in phase III testing with some results due next year.
Latest news
-
AbbVie’s uterine fibroids drug aces second phase III trial
Last year, Takeda and Myovant reported positive mid-stage results with their relugolix candidate in this indication as well as endometriosis-related pain and prostate cancer.
-
Roivant gets $1.1bn investment from Japan's SoftBank
Axovant for example is developing a GSK cast-off for Alzheimer's disease - serotonin 5-HT6 receptor antagonist RVT-101 - through late-stage testing, while Myovant is working on relugolix, a
-
Takeda forms new women's health and cancer company
For its tie-up with Takeda, the Japanese firm has granted Myovant Sciences an exclusive, worldwide license for its prostate cancer candidate relugolix, with the exception of Asian markets. ... Andrew Plump, chief medical and scientific officer at Takeda,
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
Featured jobs
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
-
Senior Training Manager - Surrey
-
Competitive Salary &Bonus
- Senior Writer, Healthcare Advertising, London
-
Excellent package
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
-
Healthcare PR Senior Account Manager
-
Salary TBC
-
Senior Medical Writer
-
Salary is DOE
- Sudler London - Senior Medical Writer
-
Competitive
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Sudler London - Account Director
-
Competitive
- Senior Medical Writer, Principal Medical Writer, Scientific Dire...
-
£40000 - £75000 Bonus Benefits
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Account Manager, Healthcare Advertising
-
£30 - 38, 000 (or -)
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Medical Writers Required - Hertfordshire
-
Competitive
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Integrated Brand/ Digital Senior Account Director, London
-
Excellent package
- Senior Medical Writer, MedComms Agency
-
Salary TBC
Subscribe to our email news alerts
- Innovate UK supports AI drug discovery project worth £1m
- Nurturing the growth mindset: The need for ongoing professional development in strategic medical communications
- Superhuman editor wins promotion at Porterhouse Medical
- Kymriah rejected in DLBCL - but NICE wants to keep talking about cost effectiveness
- Biotech leaders jump into US free speech debate
- Viking throws down gauntlet in NASH battle
PMHub
Attigo (part of the Mednet Group)
We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...
Latest intelligence
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
- What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
- GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....
Quick links
Infographics
